Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy causes temporary hair loss and discomfort, while tamoxifen has minimal hair effects.

Scalp cooling therapy is costly and often not covered by insurance, limiting access for low-income patients.

Oral tofacitinib may effectively regrow hair in children with alopecia areata unresponsive to other treatments.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Two patients with a rare scalp fungus in Poland were successfully treated with griseofulvin and ciclopirox.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

The nano-carrier makes etoposide safer and more effective against lung cancer.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

Tangent screens help detect visual field defects from vigabatrin.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Cyclosporine A slows down hair loss from chemotherapy in mice, while dexamethasone increases hair loss but speeds up regrowth.

Most women undergoing chemotherapy experience hair loss, and many cope by using wigs or bonnets.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Improving hair health and managing conditions can enhance scalp cooling effectiveness in preventing hair loss during chemotherapy.

Tofacitinib may help treat hair loss in children with alopecia areata.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.